Seeing Is Believing
PACB is currently covered by 13 analysts with an average price target of $2.91. This is a potential upside of $1.53 (110.87%) from yesterday's end of day stock price of $1.38.
Pacific Biosciences of California's activity chart (see below) currently has 71 price targets and 90 ratings on display. The stock rating distribution of PACB is 60.98% BUY and 39.02% HOLD.
Analysts average stock forecasts to be materialized ratio is 58.73% with an average time for these price targets to be met of 192.33 days.
Highest price target for PACB is $3.5, Lowest price target is $1.25, average price target is $2.26.
Most recent stock forecast was given by LUKE SERGOTT from BARCLAYS on 25-Jun-2025. First documented stock forecast 27-Aug-2015.
Currently out of the existing stock ratings of PACB, 25 are a BUY (60.98%), 16 are a HOLD (39.02%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$1.5
$0.12 (8.70%)
$2
1 months 13 days ago
(25-Jun-2025)
6/6 (100%)
$0.28 (22.95%)
14
Hold
$1.25
$-0.13 (-9.42%)
$2
2 months 23 days ago
(15-May-2025)
7/9 (77.78%)
$0.19 (17.92%)
137
Buy
$1.8
$0.42 (30.43%)
$2.5
2 months 23 days ago
(15-May-2025)
0/3 (0%)
$0.74 (69.81%)
Buy
$3
$1.62 (117.39%)
$3
3 months 28 days ago
(10-Apr-2025)
5/13 (38.46%)
$1.62 (117.39%)
123
Buy
$2
$0.62 (44.93%)
$6
4 months 13 days ago
(25-Mar-2025)
2/5 (40%)
$0.69 (52.67%)
26
What is PACB (Pacific Biosciences of California) average time for price targets to be met?
Which analyst has the current highest performing score on PACB (Pacific Biosciences of California) with a proven track record?
Which analyst has the most public recommendations on PACB (Pacific Biosciences of California)?
Which analyst is the currently most bullish on PACB (Pacific Biosciences of California)?
Which analyst is the currently most reserved on PACB (Pacific Biosciences of California)?